Status:
UNKNOWN
Viagra for the Treatment of IUGR
Lead Sponsor:
Rambam Health Care Campus
Conditions:
IUGR
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
It has been suggested that Viagra (or other drugs that inhibit PDE-5, the enzyme that normally inhibits blood vessels' ability to expand) may have beneficial effects in hypertensive pregnancy and, pos...
Detailed Description
Each participant will receive, after informed consent a 25 mg tablet of Viagra \[sildenafil citrate \]orally. The uteroplacental perfusion will be measured using transvaginal and transabdominal ultras...
Eligibility Criteria
Inclusion
- IUGR/PET/Pregnancy weeks 24-33.
- Informed consent.
Exclusion
- Maternal cardiovascular morbidity.
- Usage of any vasodilator medication
- Smoking
- Diabetes
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00347867
Start Date
July 1 2006
Last Update
July 4 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RAMBAM Health Care Campus
Haifa, Israel, 31096